Second Vietnam-produced COVID-19 vaccine to begin human trials soon

Volunteers register to participate in NACOVAX trials. (Photo: VNA)

COVIVAC has been developed by the Institute of Vaccines and Medical Biologicals (IVAC) based in the south-central province of Khanh Hoa.

Volunteers will begin trials this month at the Ha Noi Medical University in the capital. It has already been tested on rabbits and mice.

This is the second Vietnam-produced COVID-19 vaccine to be tested on humans. The country is expected to start clinical trials on the third vaccine in March.

According to Minister Long, Viet Nam is one of the few ASEAN countries that have the COVID-19 vaccine tested on humans. In addition, Viet Nam has been one of the first four countries to perform the gene sequencing of the SARS-CoV-2 and one of the five countries that can produce antibody diagnostic bio-products.

On December 17, 2020, the first Vietnam-made COVID-19 vaccine NANOCOVAX developed by Nanogen Pharmaceutical Biotechnology JSC started human trials with volunteers receiving the first doses at the Military Medical University in Ha Noi.

The volunteers remain in a healthy condition after receiving two doses each.

Prime Minister urges strong measures to accelerate COVID-19 vaccine testing Prime Minister Nguyen Xuan Phuc on December 21 asked vaccine research units to take strong measures, and suitable and creative methods to speed up vaccine ...

Strict COVID-19 prevention measures must be maintained: Meeting Strict prevention and control measures are still needed as Vietnam would only massively provide a COVID-19 vaccine in the second quarter of 2022 at the ...

Get ready for the COVID-19 vaccine transportation TGVN. The world is racing to find a COVID-19 vaccine. This generates great concern as to how the aviation sector can play its role to ...